BioLink Life Sciences is a biopharmaceutical technology company targeting major chronic diseases with innovative drug treatments. BioLink’s exclusive drug therapies support disease management initiatives to enhance the quality of life and care of patients while improving patient tolerability and decreasing drug costs. The Company is developing a robust pipeline of novel treatments for osteoporosis, iron deficiencies, kidney disease, diabetes, and seizure disorders. The NDA for Phosveda(R), a treatment for hyperphosphatemia, is under FDA review. Submissions for New Dietary Ingredients have been presented to the FDA.
Session ID: 528975